Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Aileen Bryson, RPS Scotland’s practice and policy lead, discusses the Falsified Medicines Directive (FMD)

“The FMD is designed to protect patients by minimising the chances of counterfeit medicines entering into the established medicines supply chain across Europe," says Aileen Bryson, practice and policy lead at RPS Scotland

Source  Royal Pharmaceutical Society